Another one bites the dust. After agreeing to sell itself to Covidien PLC for $2.6 billion, ev3 Inc. (NASDAQ: EVVV) becomes the third publicly traded Minnesota device firm to be acquired in just over a month. Dublin, Ireland-based Covidien agreed to pay $22.50 per share for ev3, a 19 percent premium over the vascular device […]
Medical device companies agree the fast-growing peripheral vascular (PV) market is the place to be. The question is how are they going to get there? Devices that open clogged arteries below the waist are growing 10 percent to 12 percent a year, more than twice the growth rate of coronary products. Doctors have been generally […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.